P
PYC
PYC THERAPEUTICS
1.08
-0.02-1.82%Closed16:10 01/22 AEDT
OPEN/PREV CLOSE1.100/1.100
TODAY RANGE1.065-1.110
VOL964.36K
MARKET CAP503.94M
52 WEEK RANGE0.073-2.000
AVG VOL (3M)1.17M
% TURNOVER0.21%
TURNOVER1.05M
P/E (TTM)-11.4044
% RANGE4.09%
EPS(TTM)-0.0947
P/E(FORWARD)-10.7463
P/B6.33
BVPS0.171
DIVIDEND--
P/S22.31
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP205.42M
SHARES OUTSTANDING466.61M
NEXT EARNINGS02/25-03/02
FREE FLOAT190.20M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
The Motley Fool·2d ago
Why Australian Ethical, PYC, Resolute, and Star shares are falling today
ASX·12/15/2024 22:17
PYC Nominates Fourth Clinical Drug Candidate in PMS Program
The Motley Fool·12/05/2024 19:00
2 ASX healthcare small-cap shares to buy now: brokers
ASX·11/28/2024 00:52
Polycystic Kidney Disease Program Investor Presentation
ASX·11/27/2024 06:56
Notification of cessation of securities - PYC
ASX·11/27/2024 06:54
Notification regarding unquoted securities - PYC
ASX·11/27/2024 06:04
Change of Director's Interest Notice
ASX·11/26/2024 22:02
PYC to Progress Kidney Drug Candidate Into Human Trials
Dow Jones·11/25/2024 22:10
*PYC Therapeutics Price Target Raised 8% to A$2.70/Share by Bell Potter
ASX·11/14/2024 05:26
Share Consolidation and ASX Code
ASX·11/13/2024 04:08
Update - Consolidation/Split - PYC
ASX·11/13/2024 04:04
Results of Annual General Meeting
ASX·11/12/2024 22:32
2024 AGM Chairman's Address and CEO Presentation
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others